{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:26:50Z","timestamp":1780550810845,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.steroids.2022.109056","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T11:22:53Z","timestamp":1653996173000},"page":"109056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Steroid profile in dried blood spots by liquid chromatography tandem mass spectrometry: Application to newborn screening for congenital adrenal hyperplasia in China"],"prefix":"10.1016","volume":"185","author":[{"given":"Xia","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianshu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1-2","key":"10.1016\/j.steroids.2022.109056_b0005","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.mce.2008.10.007","article-title":"Steroid measurement with LC-MS\/MS in pediatric endocrinology","volume":"301","author":"Rauh","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"issue":"7","key":"10.1016\/j.steroids.2022.109056_b0010","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1210\/jc.2006-2890","article-title":"Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry","volume":"92","author":"Janzen","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.steroids.2022.109056_b0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12020-016-1189-x","article-title":"Clinical perspectives in congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency","volume":"55","author":"Bulsari","year":"2017","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.steroids.2022.109056_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1297\/cpe.25.1","article-title":"Neonatal mass screening for 21-hydroxylase deficiency","volume":"25","author":"Tajima","year":"2016","journal-title":"Clin. Pediatr. Endocrinol."},{"key":"10.1016\/j.steroids.2022.109056_b0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/jpem-2018-0342","article-title":"A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing","volume":"32","author":"Gong","year":"2019","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.steroids.2022.109056_b0030","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/jcem-45-5-1003","article-title":"Microfilter paper method for 17\u03b1-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia","volume":"45","author":"Pang","year":"1977","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.steroids.2022.109056_b0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/gim.2011.5","article-title":"The impact of false-positive newborn screening results on families: a qualitative study","volume":"14","author":"Schmidt","year":"2012","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.steroids.2022.109056_b0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MED.0000000000000028","article-title":"Changing perspectives in screening for congenital hypothyroidism and congenital adrenal hyperplasia","volume":"21","author":"Mitchell","year":"2014","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"8","key":"10.1016\/j.steroids.2022.109056_b0045","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1210\/jc.2003-032235","article-title":"Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia","volume":"89","author":"Minutti","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.steroids.2022.109056_b0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1530\/EC-13-0023","article-title":"Multisteroid LC\u2013MS\/MS assay for glucocorticoids and androgens and its application in Addison\u2019s disease","volume":"2","author":"Methlie","year":"2013","journal-title":"Endocr. Connect."},{"issue":"4","key":"10.1016\/j.steroids.2022.109056_b0055","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10545-007-0691-y","article-title":"Reduction of the false-positive rate in newborn screening by implementation of MS\/MS-based second-tier tests: The Mayo Clinic experience (2004\u20132007)","volume":"30","author":"Matern","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.steroids.2022.109056_b0060","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jpeds.2014.01.038","article-title":"Comparison of newborn screening protocols for congenital adrenal hyperplasia in preterm infants","volume":"164","author":"Sarafoglou","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.steroids.2022.109056_b0065","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000439380","article-title":"Concurrent confirmation and differential diagnosis of congenital adrenal hyperplasia from dried blood spots: application of a second-tier LC-MS\/MS assay in a cross-border cooperation for newborn screening","volume":"84","author":"Monostori","year":"2015","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.steroids.2022.109056_b0070","unstructured":"P. Wayne, Defining, Establishing , and Verifying Reference Intervals in the Clinical Laboratory\u00a0; Approved Guideline. Third Edition. C28-A3, CLSI. 28 (2008)."},{"key":"10.1016\/j.steroids.2022.109056_b0075","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1210\/jc.2006-2890","article-title":"Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry","volume":"92","author":"Janzen","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2022.109056_b0080","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4155\/bio.16.6","article-title":"Determination of a steroid profile in heel prick blood using LC-MS\/MS","volume":"8","author":"Boelen","year":"2016","journal-title":"Bioanalysis"},{"key":"10.1016\/j.steroids.2022.109056_b0085","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3343\/alm.2015.35.6.578","article-title":"Dried blood spot testing for seven steroids using liquid chromatography-tandem mass spectrometry with reference interval determination in the Korean population","volume":"35","author":"Kim","year":"2015","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.steroids.2022.109056_b0090","doi-asserted-by":"crossref","DOI":"10.1515\/jpm-2013-0154","article-title":"Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation","volume":"42","author":"Seo","year":"2014","journal-title":"J. Perinat. Med."},{"issue":"5","key":"10.1016\/j.steroids.2022.109056_b0095","doi-asserted-by":"crossref","first-page":"e1261","DOI":"10.1542\/peds.2012-1219","article-title":"Comparison of one-tier and two-tier newborn screening metrics for congenital adrenal hyperplasia","volume":"130","author":"Sarafoglou","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.steroids.2022.109056_b0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/adc.54.5.347","article-title":"Plasma 17OH-progesterone concentrations in newborn infants","volume":"54","author":"Hughes","year":"1979","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.steroids.2022.109056_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgmr.2016.02.005","article-title":"Newborn screening for congenital adrenal hyperplasia in New York State","volume":"7","author":"Pearce","year":"2016","journal-title":"Mol. Genet. Metab. Reports."},{"key":"10.1016\/j.steroids.2022.109056_b0110","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000501396","article-title":"Congenital adrenal hyperplasia: time to replace 17OHP with 21-deoxycortisol","volume":"91","author":"Miller","year":"2019","journal-title":"Horm. Res. Paediatr."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X22000940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X22000940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:08:42Z","timestamp":1758535722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X22000940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":22,"alternative-id":["S0039128X22000940"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2022.109056","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Steroid profile in dried blood spots by liquid chromatography tandem mass spectrometry: Application to newborn screening for congenital adrenal hyperplasia in China","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2022.109056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109056"}}